Ovation Science Inc. (OVAT:CSE).
November 15 2018
Shares Issued, Outstanding
With over 30 years of entrepreneurial, business management and market initialization experience, Terry Howlett drives and directs Ovation Sciences’ development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation (he founded Skinvisible, Inc. in 1998), strategic planning and business growth; specializing in venture capital financing. You can contact Terry at 702.433.7154 or via email: email@example.com
Nature Of The business
Ovation Science is an innovative drug development company with a high performance patented topical and transdermal delivery system called Invisicare® which enhances the delivery of cannabis and other ingredients to and through the skin.
Using pharmaceutical drug development protocols and innovation, Ovation Science has developed topical and transdermal cannabis product formulations; all delivered by Invisicare®. Our technology and formulations are licensed to national and international companies that are branding experts that manufacture and market these products globally.